BIOSTRATUM
BioStratum, Inc. develops and commercializes therapeutic agents for the treatment of diabetes and diabetic complications. Its products include Pyridorin, a small molecule drug for the treatment of diabetic kidney disease; and pre-clinical compounds that treat diabetic complications and cancer. The company was founded in 1994 and is headquartered in Durham, North Carolina.
BIOSTRATUM
Industry:
Biotechnology Health Care Therapeutics
Founded:
1994-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.biostratum.com
Total Employee:
1+
Status:
Closed
Contact:
919-572-6515
Total Funding:
10.1 M USD
Technology used in webpage:
SPF IPv6 Liquid Web ParkLogic DNS
Similar Organizations
Innovative Healthcare
Innovative Healthcare develops therapeutics for the treatment of diabetes and chronic wounds.
OncoGenex
OncoGenex develops and commercializes innovative therapies for the treatment of a variety of cancers.
Current Employees Featured
Founder
Investors List
HealthCap
HealthCap investment in Venture Round - BioStratum
BankInvest
BankInvest investment in Venture Round - BioStratum
Liftaeknisjodurinn HF
Liftaeknisjodurinn HF investment in Venture Round - BioStratum
Equity Resources Group
Equity Resources Group investment in Venture Round - BioStratum
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2007-07-06 | NephroGenex | BioStratum investment in Series A - NephroGenex | 3.3 M USD |
Official Site Inspections
http://www.biostratum.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 13.248.169.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "BioStratum"
BioStratum 2025 Company Profile: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for BioStratum. Use the PitchBook Platform to explore the full profile.See details»
BioStratum Company Profile | Management and Employees List
BioStratum Profile and History BioStratum is a world leader in basal lamina research and is focused on the discovery and development of novel therapeutic agents for the treatment of …See details»
BioStratum - Overview, News & Similar companies | ZoomInfo.com
View BioStratum (www.biostratum.com) location in North Carolina, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
BioStratum Inc - Company Profile and News - Bloomberg Markets
Company profile page for BioStratum Inc including stock price, company news, executives, board members, and contact informationSee details»
BioStratum - Crunchbase Company Profile & Funding
BioStratum develops and commercializes therapeutic agents for the treatment of diabetes and diabetic complications.See details»
BioStratum - Products, Competitors, Financials, Employees, …
Mar 20, 2018 BioStratum is a pharmaceutical company developing therapeutic agents for the treatment of diabetes. Use the CB Insights Platform to explore BioStratum's full profile.See details»
Biostratum Incorporated Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Biostratum Incorporated of Durham, NC. Get the latest business insights from Dun & Bradstreet.See details»
BioStratum, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore BioStratum, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 1 news, and 4 literature, Disease Domain:Endocrinology and Metabolic Disease, …See details»
BioStratum company information, funding & investors | Dealroom.co
BioStratum, and commercializes therapeutic agents for the treatment of diabetes and diabetic complications. Here you'll find information about their funding, investors and team.See details»
BioStratum - Tracxn
BioStratum - Developer of therapeutic agents for the treatment of diabetes and diabetic complications. Raised a total funding of $600K over 1 round.See details»
BIOSTRATUM, INC. | TREA
76337948 - BIOSTRATUM Serial number 76337948 Registration number 2848191 Filing date Nov 15, 2001 Biostratum, Inc. 5 - Pharmaceutical and veterinary preparations …See details»
BioStratum - VentureRadar
BioStratum VentureRadar profile. Find out more about BioStratum including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Biostratum Inc. - BioCentury Company Profiles - BCIQ
Jul 14, 2014 Biostratum Inc. Headquarters: Durham, NC, United States of America Website: N/A Year Founded: 1994See details»
BioStratum - Funding, Financials, Valuation & Investors
BioStratum develops and commercializes therapeutic agents for the treatment of diabetes and diabetic complications.See details»
BIOSTRATUM - Biostratum, Inc. Trademark Registration
Jan 26, 2000 Trademark registration by Biostratum, Inc. for the trademark BIOSTRATUM.See details»
Biostratum Incorporated Company Profile - Dun & Bradstreet
Biostratum Incorporated Company Profile | Durham, NC | Competitors, Financials & Contacts - Dun & BradstreetHOME / BUSINESS DIRECTORY / PROFESSIONAL, SCIENTIFIC, AND …See details»
BST-1004 - Drug Targets, Indications, Patents - Synapse
May 17, 2025 BST-1004: a LAMC2 inhibitors Drug, Initially developed by BioStratum, Inc., Now, its global highest R&D status is Discontinued, Mechanism: LAMC2 inhibitors (laminin subunit …See details»
BioStratum - Tech Stack, Apps, Patents & Trademarks
May 11, 2025 BioStratum develops and commercializes therapeutic agents for the treatment of diabetes and diabetic complications.See details»
BIOSTRATUM (PTY) LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for BIOSTRATUM (PTY) LTD of OATLANDS NORTH, EASTERN CAPE. Get the latest business insights from …See details»
BST-1002 - Drug Targets, Indications, Patents - Synapse
May 7, 2025 BST-1002, Initially developed by BioStratum, Inc., Now, its global highest R&D status is Discontinued, Therapeutic Areas: Neoplasms.See details»